Klas-PDT is a novel technology originating from Ulster University introducing a new novel therapy for the treatment of malignant Melanoma.
Our technology offers potential for an effective therapy for malignant melanoma that reduces tumour size with minimal systemic side effects and scarring, at a fraction of the cost of current immune based treatments.
Company Details
- Employees
- 5
- Industry
- Health And Human Services
- NAICS
-
Administration of Human Resource ProgramsAdministration of Veterans' Affairs
Klastherapeutics Questions
Klastherapeutics's website is https://klastherapeutics.com/landing-page/
Klastherapeutics's LinkedIn profile is https://www.linkedin.com/company/klastherapeutics
Klastherapeutics has
5 employees.
View email and phone details for 5
employees at Klastherapeutics.
Klastherapeutics's industry is
Health and Human Services
Klastherapeutics's top competitors are
Chimac,
Movetru®,
Nunabio Limited,
Cotter Agritech,
Sports Impact Technologies,
Hexislab,
Dia Beta Labs Ltd,
Signacor,
Everywhere English,
6d-Dementia.
Klastherapeutics's categories are Health and Human Services
